OBR Green Articles (Leukemia (includes ALL, AML, APL, CLL, CML, MDS, Myeloproliferative Disorders, Myelofibrosis))


January 2020Edition

This year's ASH came and went, but the clinical legacy is here to stay. Trials in AML (QUAZAR) and r/r multiple myeloma (CANDOR) reflected significant advances in the treatment of those blood cancers. Meanwhile, outcomes from several trials in MCL t...